Creekmur Asset Management LLC Has $478,000 Stock Holdings in Mettler-Toledo International, Inc. $MTD

Creekmur Asset Management LLC raised its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 33.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 407 shares of the medical instruments supplier’s stock after purchasing an additional 103 shares during the quarter. Creekmur Asset Management LLC’s holdings in Mettler-Toledo International were worth $478,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of Mettler-Toledo International by 1.2% during the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock worth $3,003,485,000 after buying an additional 30,535 shares in the last quarter. Alliancebernstein L.P. increased its position in Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after acquiring an additional 126,147 shares during the period. Price T Rowe Associates Inc. MD increased its position in Mettler-Toledo International by 5.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock worth $568,032,000 after acquiring an additional 25,272 shares during the period. T. Rowe Price Investment Management Inc. increased its position in Mettler-Toledo International by 11.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock worth $479,673,000 after acquiring an additional 43,082 shares during the period. Finally, PineStone Asset Management Inc. increased its position in Mettler-Toledo International by 41.9% during the second quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock worth $392,766,000 after acquiring an additional 98,737 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on MTD shares. Barclays raised their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Weiss Ratings restated a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Bank of America raised their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Finally, Robert W. Baird raised their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International presently has an average rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Stock Down 1.5%

Mettler-Toledo International stock opened at $1,373.40 on Friday. The business’s 50-day moving average price is $1,304.55 and its two-hundred day moving average price is $1,218.30. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,454.68. The stock has a market cap of $28.29 billion, a PE ratio of 34.78, a P/E/G ratio of 4.19 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same period last year, the company posted $9.65 EPS. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. As a group, analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Activity

In other news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director owned 283 shares in the company, valued at approximately $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 1,827 shares of company stock worth $2,371,208. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.